Abbott Laboratories (Pakistan) Limited (ABOT) announcements
Everything Abbott Laboratories (Pakistan) Limited has filed with the Pakistan Stock Exchange, newest first: financial results, insider trades, material information and notices.
- NoticeTransmission of Quarterly Reports for the Period Ended September 30, 2026
- Financial resultAbbott Laboratories (Pakistan) Limited reported a strong financial performance for the nine months ended September 30, 2026Filed as: Financial Results for the Quarter Ended September 30, 2026
- NoticeBoard Meeting
- NoticeTransmission of Quarterly Financial Statements for the Period Ended June 30, 2026
- NoticeBoard Meeting
- NoticeRe-Appointment of Chairman
- NoticeRe-Appointment of Chief Executive Officer
- NoticeDissemination of Video Recording Link of Corporate Briefing Session (CBS) 2026
- NoticeRevised Presentation of Corporate Briefing Session 2026
- Financial resultFinancial Results for the Quarter Ended March 31, 2026Abbott Laboratories (Pakistan) Limited reported a strong financial performance for Q1 2026 with net profit increasing to Rs 1.94 billion and net sales reaching Rs 17.70 billion.
- Financial resultAbbott Laboratories (Pakistan) Limited reported a strong financial performance for the year ended December 31st, 2025Filed as: Financial Results for the Year Ended December 31, 2025
Showing the latest 11. Source: company filings on the Pakistan Stock Exchange. Summaries are written from the filings by software and can contain errors; the filing itself is the record. Investing in securities involves risk, including possible loss of principal.